China Oncology ›› 2018, Vol. 28 ›› Issue (8): 614-621.doi: 10.19401/j.cnki.1007-3639.2018.08.009

Previous Articles     Next Articles

Diagnosis and management of giant cell tumor of bone in the spine: a brief review

HUANG Wending1, CAI Weiluo1, LI Junkuan2, YAN Wangjun1   

  1. 1. Department of Musculoskeletal Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China; 2. No. 92493, PLA Navy, Huludao 125000,
    Liaoning Province, China
  • Online:2018-08-30 Published:2018-09-14
  • Contact: YAN Wangjun E-mail: spinetumor@163.com

Abstract: Giant cell tumors of bone (GCTB) in the spine are rarely seen, and the diagnosis relies on clinical presentations, imaging and pathology. The treatment of spinal giant cell tumor is difficult because there is no evidencebased management guidelines and consensus. Surgery is still the first choice for management of the spinal giant cell tumor. Preoperative arterial embolization and complete surgical removal with postoperative denosumab are the recommended treatment methods. En bloc resection is an ideal treatment for spinal giant cell tumors, but surgeons must carefully evaluate patients individually. Denosumab is indicated for patients with unresectable/recurrent/metastatic GCTB. It can effectively reduce the stage of giant GCTB and create conditions for en bloc resection.

Key words: Spine, Giant cell tumor of bone, Surgery, Adjuvant therapy